Consistent with findings in mESCs (Appendix Fig S2D), CDK1 knock‐down reduced the p‐TFCP2L1 level in T24 (Fig 5D) and basal subtype (Fig EV5F) BC cells. Here, TFCP2L1 is linked to breast cancer.